aid: medeor-therapeutics
name: Medeor Therapeutics
description: >-
  Medeor Therapeutics is a clinical-stage cellular immunotherapy company in San Mateo, California,
  developing MDR-101, a one-time cell therapy manufactured from a living kidney donor's blood that
  induces mixed chimerism so HLA-matched transplant recipients can withdraw from lifelong
  immunosuppression while preserving graft function. The platform originated in roughly two decades
  of research at Stanford University led by Dr. Samuel Strober. The company completed a Phase 3
  registration trial that exceeded its target success rate, and has since suspended operations and
  is seeking an acquirer to complete the BLA filing. Medeor is a therapeutics developer, not a
  software company: it publishes no developer portal, API, SDK, or machine-readable specification.
url: https://raw.githubusercontent.com/api-evangelist/medeor-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
deliveryModel:
  model: unknown
  open_source: false
  commercial: false
  callable_host: false
  label: Delivery model not determined — needs a product licence on record
  confidence: low
  source:
  - none
  generated: '2026-08-28'
  method: derived
specificationVersion: '0.20'
created: '2026-08-25'
modified: '2026-08-25'
tags:
- Company
- Biotechnology
- Life Sciences
- Cell Therapy
- Immunotherapy
- Organ Transplant
- Healthcare
- Clinical Trials
- Pharmaceuticals
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://medeortx.com/
- type: PrivacyPolicy
  url: https://medeortx.com/privacy-policy.php
- type: News
  url: https://medeortx.com/news.php
- type: LinkedIn
  url: https://www.linkedin.com/company/medeor-therapeutics/
- type: SecondaryMarketListing
  url: https://forgeglobal.com/medeor-therapeutics_stock/
- type: DomainSecurity
  url: security/medeor-therapeutics-domain-security.yml
x-enrichment:
  date: '2026-08-25'
  status: minimal
  artifacts_added: 2
  pass: local-v1
x-coverage:
  state: none
  reason: defunct
  detail: >-
    medeortx.com serves a live homepage whose lead paragraph states Medeor has suspended operations
    and is seeking an acquirer to complete the BLA filing, leaving a clinical-trial archive site
    with no developer, API, or data surface of any kind.
  evidence:
  - url: https://medeortx.com/
    status: 200
  - url: https://medeortx.com/openapi.json
    status: 404
  - url: https://medeortx.com/llms.txt
    status: 404
  - url: https://medeortx.com/.well-known/api-catalog
    status: 404
  - url: https://github.com/medeortx
    status: 404
  checked: '2026-08-25'